The PREDICT Registry: (NCT03448926)
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
🩺 Plain-English Summary (8th-Grade Level)
This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions. Patients meeting the eligibility criteria (see below) will be eligible for participation and the investigators will obtain written informed consent. A central Institutional Review Board (IRB), WCG IRB, will approve the protocol and each participating institution.
Who can join: Review the eligibility criteria below.
Location: Arizona Center for Cancer Care — Scottsdale, Arizona
Age range: 30 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (30 Sites)
Showing the first 25 of 30 sites.
- Arizona Center for Cancer Care — Scottsdale, Arizona
- University of California San Diego — La Jolla, California
- Sutter Health — San Mateo, California
- University of Colorado Anschutz Medical Campus — Aurora, Colorado
- Baptist MD Anderson Cancer Center — Jacksonville, Florida
- BayCare Health System — Tampa, Florida
- University of South Florida — Tampa, Florida
- Emory University Winship Cancer Institute — Atlanta, Georgia
- Endeavor Health (Northshore) — Evanston, Illinois
- MedStar Health Research Institute — Baltimore, Maryland
- Dana-Farber Cancer Institute — Boston, Massachusetts
- Corewell Health William Beaumont University Center — Royal Oak, Michigan
- Comprehensive Breast Care — Troy, Michigan
- Washington University School of Medicine — St Louis, Missouri
- Maimonides Cancer Center — Brooklyn, New York
- Northwell Health Center for Advanced Medicine — Lake Success, New York
- NYU - Long Island — Mineola, New York
- NYU - Manhattan — New York, New York
- Columbia University Medical Center — New York, New York
- Cleveland Clinic Akron General — Akron, Ohio
- Cleveland Clinic Foundation-Taussig Cancer Inst — Cleveland, Ohio
- The Ohio State University — Columbus, Ohio
- Compass Oncology — Tigard, Oregon
- St Luke's University Health Network — Easton, Pennsylvania
- Sidney Kimmel Comprehensive Cancer Ctr - Jefferson — Philadelphia, Pennsylvania
📞 Contact the Study Coordinator
Phone: (813) 215-1749
Email: sshivers@preludedx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in DCIS
- Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS — Anchorage, Alaska
- Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) — Calgary, Alberta
- Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ — Houston, Texas
Explore by condition: All DCIS clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.